We are live on ! Find out more
SURF

Surface Oncology, Inc. Common Stock

Delisted

SURF was delisted on the 7th of September, 2023.

29 hedge funds and large institutions have $26.8M invested in Surface Oncology, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $26.1M → $26.8M (+$706K)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

15% less funds holding

Funds holding: 3429 (-5)

46% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 13

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
29
Holders Change
-5
Holders Change %
-14.71%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
7
Reduced
13
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MAM
26
Meeder Asset Management
Ohio
$1K -$10.3K -3,893 -87%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$1K +$854 +324 +245%
BNP Paribas Financial Markets
28
BNP Paribas Financial Markets
France
$122
RC
29
RBF Capital
California
-$88K -46,218 Closed
PAM
30
PVG Asset Management
Colorado
-$51K -27,142 Closed
BCM
31
Beddow Capital Management
Wyoming
-$47K -25,000 Closed
Barclays
32
Barclays
United Kingdom
-$38K -20,317 Closed
HF
33
HRT Financial
New York
-$37K -19,948 Closed
Deutsche Bank
34
Deutsche Bank
Germany
-$8K -4,508 Closed
BBHC
35
Brown Brothers Harriman & Co
New York
-$3K -1,838 Closed
Citigroup
36
Citigroup
New York
-$2K -1,281 Closed
Wells Fargo
37
Wells Fargo
California
+$166 +63 New

SURF Hedge Fund Activity: Q1 2020 in Review

29 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q1 2020, worth a combined $26.8M — up 2.7% from $26.1M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of SURF and 3 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 7 added.

The largest buyer was Victory Capital Management, adding an estimated $2.27M. The largest seller was BVF Inc, cutting an estimated $272K.

  • 29 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q1 2020, down from 34 in Q4 2019.
  • Funds reported $26.8M of Surface Oncology, Inc. Common Stock stock for Q1 2020, up 2.7% quarter-over-quarter.
  • 3 funds opened new Surface Oncology, Inc. Common Stock positions in Q1 2020 and 8 closed out, a net change of -5 holders.
  • The largest Surface Oncology, Inc. Common Stock buyer in Q1 2020 was Victory Capital Management, an estimated $2.27M added.
  • The largest Surface Oncology, Inc. Common Stock seller in Q1 2020 was BVF Inc, an estimated $272K sold.

Based on aggregated 13F filings for Q1 2020.